Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trial.

Saved in:
Bibliographic Details
Title: Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trial.
Authors: Komarow HD; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Md., Wang J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Md., Eisch R; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Md., Scott L; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Md., Brittain EH; Biostatistics Research Branch, Division of Clinical Research, NIAID, NIH, Bethesda, Md., Metcalfe DD; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Md.
Source: The journal of allergy and clinical immunology. Global [J Allergy Clin Immunol Glob] 2025 May 21; Vol. 4 (3), pp. 100498. Date of Electronic Publication: 2025 May 21 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918453488706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-8293 (Electronic) Linking ISSN: 27728293 NLM ISO Abbreviation: J Allergy Clin Immunol Glob Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2772-8293
DOI:10.1016/j.jacig.2025.100498